StreetAlpha.app
Home › Stocks › SGHT

Sight Sciences, Inc. (SGHT)

Healthcare
$10.18
▼ −4.14%
LAST CLOSE · NOV 20

Sight Sciences sells medical devices for treating glaucoma and dry eye disease, based in Menlo Park, California. It last closed at $10.18 on Nov 20, down 4.14% on the day. The next earnings report for SGHT is expected around Tue, Jan 12, 2027. For the quarter ended Sep 2026, SGHT reported EPS of -$0.12 on revenue of $24.9M, with revenue up 25.2% from a year ago. Over its last 8 reports the stock moved an average of 15.5% the session after earnings. Over the last 12 months SGHT insiders bought $185K of stock on the open market and sold $3.0M, according to SEC Form 4 filings.

AI Auto Pilots
Is SGHT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SGHT.

Key Stats

Last 12 months
Results
Revenue
$88.4M
+16.2% vs a year ago
Net income
−$28.4M
−32.1% margin
EPS (diluted)
−$0.52
Free cash flow
−$16.9M
−19.2% margin
Valuation
Market cap
$565.8M
55.6M shares
P/E
–
No P/E while losing money
Price to sales
6.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$77.4M
At Sep 30
Debt
$42.4M
At Sep 30
Shareholder equity
$49.1M
Shares outstanding
55.6M
At Oct 29
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $49.0M$49.0MFY2021FY2022: $71.3M$71.3MFY2022FY2023: $81.1M$81.1MFY2023FY2024: $79.9M$79.9MFY2024FY2025: $77.4M$77.4MFY2025

From SGHT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Jan 12
Estimated date · Time not announced
Reported EPS
-$0.12
Quarter ended Sep 2026
Year ago EPS
-$0.16
Same quarter last year
Revenue
$24.9M
+25.2% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.24Dec '24Mar 2025: -$0.28Mar '25Jun 2025: -$0.23Jun '25Sep 2025: -$0.16Sep '25Dec 2025: -$0.08Dec '25Mar 2026: -$0.24Mar '26Jun 2026: -$0.08Jun '26Sep 2026: -$0.12Sep '26Latest -$0.12
Revenue by quarter
Dec 2024: $19.1MDec '24Mar 2025: $17.5MMar '25Jun 2025: $19.6MJun '25Sep 2025: $19.9MSep '25Dec 2025: $20.4MDec '25Mar 2026: $19.7MMar '26Jun 2026: $23.4MJun '26Sep 2026: $24.9MSep '26Latest $24.9M
How SGHT moved after its last 8 reports
Average move the session after a report ±15.5%
Nov 4, 2026After the close+0.8%
Aug 5, 2026After the close+27.8%
May 6, 2026After the close+23.0%
Mar 4, 2026After the close−26.8%
Jan 13, 2026Time not announced−7.8%
Nov 6, 2025After the close+16.4%
Aug 7, 2025After the close+19.4%
May 8, 2025After the close+1.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on SGHTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on SGHT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SGHT

Technical Analysis

SGHT · as of the Nov 20 close · updated each morning
Uptrend

The stock is 1% above its 20 day and 10% above its 50 day average. It is 38% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 54). The nearest support is the 20 day average at $10.07, and the nearest resistance the Pivot at $10.33.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityNormal, 5.6%/day
Key levels
$11.6052 week high+13.9%
$11.60Swing high (Nov 12)+13.9%
$10.69Pivot R1+5.0%
$10.33Pivot+1.5%
$10.18Last close
$10.0720 day average−1.1%
$9.82Pivot S1−3.5%
$9.2150 day average−9.5%
$8.98Swing low (Nov 4)−11.8%
$7.98100 day average−21.6%
$6.29200 day average−38.2%
$3.3852 week low−66.8%
Indicators
RSI (14)54.36Middle of its rangeNeutral
MACD0.46Below its signal lineBearish
Stochastic58.9Middle of its rangeNeutral
ADX (14)35.3Trending up
Williams %R-54.2Oversold below −80, overbought above −20Neutral
CCI (20)27.9Oversold below −100, overbought above 100Neutral
Rate of change+1.0%Change over 10 sessionsBullish
ATR (14)$0.57Typical daily range, 5.6% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for SGHT

What happened before

See how SGHT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow SGHT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How SGHT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for SGHTHow many large options trades hit SGHT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

SGHT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲74 buying vs 37 selling
  • ▲Held by funds +1.7 pts
  • ▲Funds holding +19
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding131112+17.0%
In funds' top 1010–
Held by funds41.6%39.9%+1.7 pts
New / increased26 / 4816 / 43+25.4%
Reduced / sold out30 / 730 / 15−17.8%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SGHT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SGHT Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$185K2 buys · 1 insider
Sold$3.0M31 sales · 6 insiders
81% of the selling was under pre-arranged trading plans.
2025-12 bought $116K2025-12 sold $21K2026-01 sold $877K2026-04 sold $312K2026-05 sold $65K2026-06 bought $69K2026-07 sold $448K2026-10 sold $653K2026-11 sold $220KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 16Brenton TaylorEVP, Operations & R&DSale plan20,685$10.64$220K
Oct 2James RodbergCFOSale plan7,208$8.85$64K
Oct 2Alison BauerleinCOOSale plan25,260$8.85$224K
Oct 2Brenton TaylorEVP, Operations & R&DSale plan2,988$8.85$26K
Oct 1Paul BadawiPresident and CEOSale plan29,653$9.05$268K
Oct 1David BadawiChief Technology OfficerSale plan7,797$9.05$71K
Every insider buy and sale for SGHT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See SGHT insider trades →

From SEC Form 4 filings by SGHT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SGHT is in one of them and how their past SGHT trades turned out.

SGHT in the AI portfolios
Loading…

SGHT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SGHT in an article yet. Here's the latest on the wider market.

SGHT in the news

About Sight Sciences

Sight Sciences is a medical device company based in Menlo Park, California. It sells surgical devices for treating glaucoma, including the OMNI Surgical System and the SION Surgical Instrument, which surgeons use in procedures to lower eye pressure. The company also sells the TearCare system, a device for treating dry eye disease caused by blocked meibomian glands. Its customers are eye care professionals, mainly ophthalmic surgeons and eye doctors, and the patients they treat.

Headquarters
Menlo Park, CA